First-line Combination Strategy Provides Favorable 5-year Outcomes for Patients with Lupus Nephritis: A Single-center Observational Study.

Kagawa, Hidetoshi; Yamanaka, Ryutaro; Hiromasa, Tsutomu.

Afiliação

Kagawa H; Department of Nephrology and Rheumatology, Japanese Red Cross Society Himeji Hospital.
Yamanaka R; Department of Nephrology and Rheumatology, Japanese Red Cross Society Himeji Hospital.
Hiromasa T; Department of Nephrology and Rheumatology, Japanese Red Cross Society Himeji Hospital.

Acta Med Okayama ; 76(5): 547-555, 2022 Oct.

Article em En | MEDLINE | ID: mdl-36352802

Assuntos

Nefrite Lúpica; Humanos; Nefrite Lúpica/tratamento farmacológico; Nefrite Lúpica/induzido quimicamente; Imunossupressores; Resultado do Tratamento; Tacrolimo/uso terapêutico; Tacrolimo/efeitos adversos; Prednisolona/uso terapêutico; Recidiva; Quimioterapia Combinada

Palavras-chave

combination therapy; first-line therapy; lupus nephritis; mizoribine; tacrolimus